N. L. Shipkowitz

1.3k total citations
29 papers, 1.0k citations indexed

About

N. L. Shipkowitz is a scholar working on Epidemiology, Molecular Medicine and Pharmacology. According to data from OpenAlex, N. L. Shipkowitz has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Molecular Medicine and 8 papers in Pharmacology. Recurrent topics in N. L. Shipkowitz's work include Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Pneumonia and Respiratory Infections (6 papers). N. L. Shipkowitz is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Pneumonia and Respiratory Infections (6 papers). N. L. Shipkowitz collaborates with scholars based in United States and United Kingdom. N. L. Shipkowitz's co-authors include Robert R. Bower, Dwight J. Hardy, R. N. Swanson, J. B. Schleicher, Jacob J. Clement, Prabhavathi Fernandes, Lacy R. Overby, C W Hanson, J. Mao and Amanda Esch and has published in prestigious journals such as Science, Biometrics and Journal of Medicinal Chemistry.

In The Last Decade

N. L. Shipkowitz

29 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. L. Shipkowitz United States 19 484 244 239 239 173 29 1.0k
A. Percival United Kingdom 19 520 1.1× 175 0.7× 124 0.5× 156 0.7× 152 0.9× 49 1.3k
Agnès Girard United States 19 558 1.2× 308 1.3× 347 1.5× 478 2.0× 359 2.1× 39 1.5k
S. R. M. Bushby United Kingdom 19 535 1.1× 256 1.0× 291 1.2× 444 1.9× 371 2.1× 40 1.4k
D Girard United States 16 430 0.9× 141 0.6× 274 1.1× 376 1.6× 248 1.4× 29 1.0k
A. R. English United States 16 283 0.6× 271 1.1× 242 1.0× 520 2.2× 395 2.3× 45 1.3k
J. Carl Craft United States 25 755 1.6× 224 0.9× 567 2.4× 179 0.7× 99 0.6× 46 1.7k
Ron Boon United States 19 1.0k 2.1× 181 0.7× 291 1.2× 315 1.3× 113 0.7× 36 1.6k
K. W. Brammer United Kingdom 17 644 1.3× 216 0.9× 744 3.1× 175 0.7× 63 0.4× 35 1.3k
Mary E. Fling United States 16 293 0.6× 330 1.4× 377 1.6× 368 1.5× 247 1.4× 16 1.4k
M. T. Labro France 21 505 1.0× 200 0.8× 205 0.9× 322 1.3× 215 1.2× 59 1.3k

Countries citing papers authored by N. L. Shipkowitz

Since Specialization
Citations

This map shows the geographic impact of N. L. Shipkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. L. Shipkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. L. Shipkowitz more than expected).

Fields of papers citing papers by N. L. Shipkowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. L. Shipkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. L. Shipkowitz. The network helps show where N. L. Shipkowitz may publish in the future.

Co-authorship network of co-authors of N. L. Shipkowitz

This figure shows the co-authorship network connecting the top 25 collaborators of N. L. Shipkowitz. A scholar is included among the top collaborators of N. L. Shipkowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. L. Shipkowitz. N. L. Shipkowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alder, Jeff, Jacob J. Clement, Jonathan A. Meulbroek, et al.. (1995). Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infections. Antimicrobial Agents and Chemotherapy. 39(4). 971–975. 15 indexed citations
2.
Alder, J. D., et al.. (1993). Clarithromycin therapy of experimental Treponema pallidum infections in hamsters. Antimicrobial Agents and Chemotherapy. 37(4). 864–867. 6 indexed citations
3.
Hardy, Dwight J., et al.. (1991). Activity ofTemafloxacin against Respiratory Pathogens. 1 indexed citations
4.
Swanson, R. N., Dwight J. Hardy, N. L. Shipkowitz, et al.. (1991). In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile. Antimicrobial Agents and Chemotherapy. 35(6). 1108–1111. 75 indexed citations
5.
Hardy, Dwight J., R. N. Swanson, N. L. Shipkowitz, et al.. (1991). In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivatives. Antimicrobial Agents and Chemotherapy. 35(5). 922–928. 9 indexed citations
6.
Swanson, R. N., Dwight J. Hardy, N. L. Shipkowitz, et al.. (1989). Phenelfamycins, a novel complex of elfamycin-type antibiotics. III. Activity in vitro and in a hamster colitis model.. The Journal of Antibiotics. 42(1). 94–101. 5 indexed citations
7.
Shipkowitz, N. L., et al.. (1987). Murine Models for Studying the Pathogenesis and Treatment of Pyelonephritis. Advances in experimental medicine and biology. 224. 35–51. 4 indexed citations
8.
Sanathanan, Lalitha, et al.. (1987). Trimmed Logit Method for Estimating the ED50 in Quantal Bioassay. Biometrics. 43(4). 825–825. 23 indexed citations
9.
Fernandes, Prabhavathi, Robert T. Bailer, R. N. Swanson, et al.. (1986). In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrobial Agents and Chemotherapy. 30(6). 865–873. 126 indexed citations
10.
Mao, Jialin, et al.. (1985). Structure-activity studies on phosphonoacetate. Antimicrobial Agents and Chemotherapy. 27(2). 197–202. 25 indexed citations
11.
Stamm, John M., et al.. (1981). Antimicrobial Activity of Cefmenoxime (SCE-1365). Antimicrobial Agents and Chemotherapy. 19(3). 454–460. 27 indexed citations
12.
Herrin, Thomas, et al.. (1977). Synthesis and anti-herpes simplex activity of analogs of phosphonoacetic acid. Journal of Medicinal Chemistry. 20(5). 660–663. 29 indexed citations
13.
Herrin, Thomas, et al.. (1977). ChemInform Abstract: SYNTHESIS AND ANTI‐HERPES SIMPLEX ACTIVITY OF ANALOGS OF PHOSPHONOACETIC ACID. Chemischer Informationsdienst. 8(39). 5 indexed citations
14.
Shipkowitz, N. L., Robert R. Bower, Carl W. Nordeen, et al.. (1973). Suppression of Herpes Simplex Virus Infection by Phosphonoacetic Acid. Applied Microbiology. 26(3). 264–267. 93 indexed citations
15.
Shipkowitz, N. L., et al.. (1972). Antiviral Activity of a bis-Benzimidazole Against Experimental Rhinovirus Infections in Chimpanzees. Applied Microbiology. 23(1). 117–122. 19 indexed citations
16.
Shipkowitz, N. L., et al.. (1972). Antiviral Activity of a bis-Benzimidazole Against Experimental Rhinovirus Infections in Chimpanzees1. Applied Microbiology. 23(1). 117–122. 14 indexed citations
17.
Holinger, Paul H., et al.. (1968). Studies of Etiology of Laryngeal Papilloma and an Autogenous Laryngeal Papilloma Vaccine. Acta Oto-Laryngologica. 65(1-6). 63–69. 24 indexed citations
18.
Shipkowitz, N. L., et al.. (1967). Evaluation of an autogenous laryngeal papilloma vaccine. The Laryngoscope. 77(6). 1047–1067. 18 indexed citations
19.
Shipkowitz, N. L., et al.. (1966). Rabbit oral papillomatosis: ultrastructure of experimental infection.. PubMed. 26(1). 160–5. 21 indexed citations
20.
Shipkowitz, N. L., et al.. (1955). Thallium Acetate in the Diagnosis of Chronic Respiratory Disease of Chickens. Science. 122(3177). 969–970. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026